PREFACE
Excellent textbooks and review volumes on immunology, virology, parasitology, medical microbiology, and infectious diseases abound. So what gap is this book aiming to fill?
Although microbiology and immunology can look back to common beginnings 120 years ago, the fields parted ways toward the end of the 20th century and have been marching to different drums. This separation had its logic at that time. It was realized that immunology encompasses more than antimicrobial defense, and medical microbiology became more and more fascinating as our understanding of the etiologic agents of diseases increased as well as the advent of chemotherapy. This is the reason that infectious diseases were often being viewed from the microbes' or the host's perspective. Such a singular view tends to emphasize unique microbial or immune aspects instead of focusing on the true cross talk between the pathogen and the host. We therefore asked a team of experts with a true interest in the immunology of infectious diseases to review not the monologues of, but the dialogue between, pathogens and the host immune system. Instead of covering an exhaustive number of diseases, we placed emphasis on the general mechanisms underlying immune responses to infectious diseases. We hope this textbook fills a gap and helps to reestablish a deeper relationship between immunology and medical microbiology.
We express our deep appreciation and thanks to the editorial staff of ASM, in particular Greg Payne and Susan Birch. We also cordially thank our associates Caitlin McCoull, Lucia Lom-Terborg, and Vivian Kirkwood for their secretarial and administrative support. Last but not least, we are grateful to our colleagues for their efforts and valuable time. By contributing to this textbook, they have generously shared their extraordinary expertise.
Stefan H. E. Kaufmann Alan Sher Rafi Ahmed
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The concept behind this book is to examine different aspects of the host response to the plethora of infectious agents. Although we appreciate that infection is an encounter between microbe and host, this book will emphasize the host side of the interaction. We adhere to the idea that the strategies of immune defense and pathogen survival coevolved in a dynamic process. This process led simultaneously to the development of novel survival mechanisms and virulence factors in microbial pathogens and to distinct host defense mechanisms for counteracting pathogen survival. At its most polarized level, this coevolution occurred in the form of a gene-by-gene counteraction. More frequently, however, it proceeded such that a pattern of virulence factors was matched by a pattern of host defense mechanisms. In this struggle between pathogen and host, the immune system assumed responsibility for the control of the invader. Although microbes and host immune systems rely on different basic mechanisms, the outcome of their combat is delicately balanced; pathogens have not fully succeeded in controlling ''us,'' and we have not fully succeeded in controlling ''them. '' In essence, pathogens rely on rapid variability. In an attempt to directly compete with this strategy, the immune system uses recombination to produce an immense array of specific receptors, thus combining exclusive specificity with broad coverage. Aside from this, the immune system has succeeded in forming one more weapon through the development of specific memory, which allows more efficacious combat on subsequent encounters with the pathogen. Obviously, specific memory also forms the basis for vaccination, which was developed by humans using a totally different part of their bodies, namely, the intellect.
What has been said so far about host resistance relates mostly to the so-called acquired immune response, which develops slowly but is highly efficient once fully activated and is thus responsible for the eradication of most pathogens. Combined with appropriate control mechanisms, its unique specificity guarantees that the highly aggressive acquired immune response does not cause too much harm to the host itself. However, acquired immunity is not without drawbacks in the fight against microbial invaders. In particular, the primary response develops slowly and is unable to immediately control fast-replicating microbes. Hence, an additional mechanism that is capable of combating invading pathogens must be available without delay. This response must be shortlived and tightly regulated in order to avoid any exaggerated effects on the host. This is the domain of the innate immune system, a fact that was largely ignored by basic immunologists although regarded as essential by those interested in infectious diseases. Without doubt, the innate immune system is phylogenetically much older than the acquired immune system. While its generally unsophisticated response was useful in protecting species with high reproduction rates, it was insufficient for the higher vertebrates, including humans. These species needed to exploit somatic recombination to overcome the dangers inherent in low reproduction rates.
Our attitude toward the innate immune systems has changed with the awareness that it is not only a rapid response mechanism but also a critical switchboard determining the type of acquired immune response that evolves. Although the innate immune system does not distinguish between different microbial pathogens, it is vital that it distinguish foreign invaders from the host's own cells. This is achieved by so-called pattern recognition receptors, which display specificity for distinct molecular entities exclusively present in microbes.
With regard to function, the acquired immune response is composed of only two basic mechanisms, namely, direct destruction of infected target cells and activation or inhibition of effector cells. In the first mechanism, the immune system accepted damage to the host as the price to be paid for destroying the pathogen. The second mechanism is essential for regulating both the acquired and innate immune responses. In doing so, distinct functions such as antibody secretion by B cells, target cell killing by cytolytic T lymphocytes, and activation of macrophages and granulocytes must all be achieved. Moreover, this mechanism is also responsible for the downregulation of an immune response once the pathogen has been eradicated. It can be easily guessed that such a wide spectrum of effects cannot be achieved via a single route and that segregation into different routes is required. The appropriate route is selected by the innate immune system rapidly after the pathogen enters the host. Thus, acquired immunity and innate immune response regulate each other reciprocally. As we understand it now, the innate and acquired immune responses are interwoven in a mutual discourse at many stages.
It is the goal of this book to show how the dialogue between different types of pathogen and the host immune system, as well as the cross talk between the different components of the immune response, works. Although pathogen eradication is the major task of the immune response, protection is not always achieved without a price. Therefore, pathologic sequelae of infection, microbial evasion mechanisms, and the genetics of host susceptibility are all discussed in equal depth. Finally, we have turned our attention to novel ways of applying this knowledge to improve ''our'' side of the scale. Strategies of immune intervention will be discussed paradigmatically with two major microbial killers of humans. Addressins, [198] [199] 191, 195 Adenosine deaminase, 148, 254 Adenovirus, 254, [309] [310] 312, [315] [316] [317] [318] [319] [320] [321] [366] [367] 60, 93, 102, 132, 165, 167, 171, 193, 207-208, 211, 213, 236, 248-251, 256 Defensins, 62, 74, 84, 98, [105] [106] [107] [128] [129] 193, 200, 223, 253 Dementia, 321 Dendritic cells, [79] [80] 93, 96, 105, 132, [144] [145] [146] 153, [167] [168] 171, 193, 195, 197, 199, 208, 237, [250] [251] Endotoxin, 6, [214] [215] 39, 42, 113, 117 Enteritis, viral, 318, [321] [322] [193] [194] 196, 198, 200, [311] [312] 322, 89, 143, [145] [146] 150, 170, 185, 260, 271, [274] [275] 282, 289, [307] [308] [309] 311, 314, 318, 364, 367, 197-198, 200, 213-215, 283, 310 secretory, 199-202, 311-312, 322 Immunoglobulin E (IgE), 151, 163, 281, 311, 402 Immunoglobulin G (IgG), 94, 163, 179-180, 215, 255, 257, 282, 310, 335, 358-359 G1, 214, 229, 240-241, 256 G2a, 213-214, 256 G2b, 213-214, 256 G3, 214 48, 294, [297] [298] [299] 302, 338, 402 acquired immunity, [163] [164] [165] 168, [170] [171] 198, 209, [212] [213] [214] 227, 235, [239] [240] 242 innate immunity, [86] [87] 98, 102, [118] [119] [130] [131] [132] [133] 48, 116, 118, 130, 132, 151, [163] [164] [165] [197] [198] 209, [213] [214] 227, 235, [240] [241] 294, 302, 87, 100, 102, [141] [142] 144, 146, [153] [154] 198, 209, 216, 227, 287, 339, 345, 364, 192, 9, 11, 215, 339, 362, 164, [240] [241] 402 Interleukin-10 (IL-10), [294] [295] [296] [297] [298] [299] 301, 430 acquired immunity, 164, 170, [197] [198] 212, 214, 218, 227, 235, 239, 242, 260 immune evasion and latency, 345, 364, 388 innate immunity, 80, [86] [87] 98, [116] [117] [118] [130] [131] 33, 42, 48, [294] [295] [296] [297] [298] [299] 402, 413, 441, 443, [445] [446] 465, 467, 471 acquired immunity, 164, [168] [169] [170] 209, 212, 214, 237, [242] [243] 335, 344, 382 innate immunity, [86] [87] 89, [100] [101] [115] [116] [117] [129] [130] [131] 133, 139, [141] [142] 84, 105, 128, 194, 200 M cells, 193-197, 200, 202, 311-312, 342-343 M protein, 7, 218, 276, 283 47, 55, 63, 67, 70-73, 88-89, 100-102, 139, 148-149, 186, 198-199, 208, 216-217, 236, 248-249, 252-253, 269-270, 278, 289, 369-370, 379, 386-388, 422-424, 429 , 431 inhibition of antigen presentation, 366, 370 viral proteins that bind to or mislocalize, 367-369 class Ia molecules, 208-210 class Ib molecules, [88] [89] 208, [210] [211] 47, 55, 67, [70] [71] [72] [73] 88, [101] [102] 132, 149, 167, [185] [186] 199, [207] [208] [212] [213] 216, 236, 248, 256, [269] [270] 272, 277, 345, 379, 386, [422] [423] [424] 430 -431 inhibition of class II pathway, 370-371 inhibition of surface molecules, 371 polymorphism, 71-73 Major histocompatibility complex (MHC) genes, [71] [72] [73] 362, 370, [422] [423] [424] [40] [41] [45] [46] [49] [50] 293, 296, [299] [300] [301] [302] 397 biological 17, 96, [127] [128] [272] [273] 430 Mannose receptor, 16, [32] [33] 81, 94, 128, [145] [146] 197 9, [11] [12] 14, 86, 95, [145] [146] 170, [365] [366] [387] [388] 413, 443, 454 Nipah virus, 307, [314] [315] [316] [317] [318] [319] 43, [117] [118] 120, 169, [239] [240] [241] [242] 84, [97] [98] 101, [128] [129] 133, 149, [200] [201] 209, 237, 240, 254, [294] [295] [296] 300, 386, 411, 413 Nitric oxide synthase, inducible, 42, 84, 97, [115] [116] [149] [150] [237] [238] 254, 298, 302, 344, 386 [81] [82] 86, 127, 235 Paxillin, 82 PE proteins, 445 Penicillium, 284 Penicillium marneffei, 26, [29] [30] 470 Peptidoglycan, 339 Perforin, 99, 150, 152, 211, 238, 254, 286, [371] [372] [128] [129] bacterial, 6 Peyer's patches, 191, 194, [196] [197] 199, 201, 312, [342] [343] 41, 47 Phagocytes, [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] 105, [114] [115] [87] [88] [89] [81] [82] [83] [79] [80] [86] [87] 79 types and functions, [79] [80] [81] [81] [82] [83] 85, 94, 112, 250 Phagolysosome, 115, 343 Phagosome(s), 82, [216] [217] 85 maturation, [83] [84] [85] [443] [444] [84] [85] [86] [83] [84] 236, 345 inhibition, 17, 343, 407 Phase variation, pili, 340 Phenotype, 397 Phlebovirus, 15, 82, 388 Phospholipase, 15, 33 Phospholipase A, 6 Phospholipase A 2 , 105, 372 Phospholipase C, 84 Salmonella, [13] [14] 83, 85, 169, 200, 218, 271, 277, 289, 410 Salmonella enterica, [210] [211] 286 Salmonella enterica serovar Typhi, 196 chronic carriers, 342-343 persistent infection, 331-332 Salmonella enterica serovar Typhimurium, 105-106, 195-196, 216, 407-409 , 414 immunogenetics of host response, 412-413 mouse infection models, [412] [413] [81] [82] 94, 443 Schistosoma, 43, 132 immunogenetics of host response, [402] [403] 43, 297 Schistosoma japonicum, 297 Schistosoma mansoni, 113, [117] [118] 169, [293] [294] [297] [298] 302 [384] [385] [386] [387] [388] 142, 197, 201, 308, 317, 459, [463] [464] aureus, 7, 211, [214] [215] 219, 414 STAT proteins, 86, 98, [147] [148] 151, 240, 360, 362, 370, [385] [386] [387] 467 Stathmin, [15] [16] for AIDS, 470 Stevors, 47 Stratified epithelia, antigen sampling across, 193 Stratum germinativum, 309 Streptococci, group A, 271, 274, 276, 283, [288] [289] 283 Streptococcus pneumoniae, 7, 215, [288] [289] 7, 214, 218, 283 Streptokinase, 7 Streptolysins, 7 Strongyloides, 43, Th1, 42, 46, 49, [88] [89] 111, 151, 154, 209, 227, 229, 235, 252, 294, 299, 301, 382, 384, 402, 441, 446 Th2, 42, 46, 49, [88] [89] 111, 119, 151, 209, 235, 239, 252, 294, 299, 301, 382, 402, 446 67, 70, 89, 102, 119, 165, 248-253, 260, 424, 427 ␣␤, 192, 211, 381-382 cross-reactivity, 271-272 degeneracy in recognition, 270 ␥␦, 192, 212, 424, 441 T-cell repertoire, 253, 468 T-dependent antigens, 212-213, 257-258 T-independent antigens, 213, 257- 33, 69, 86, [94] [95] 100, 128, 365, 413, 443 Tonsils, 191, 195, 311 Toxic shock syndrome, 7, 219, 272 Toxin(s), bacterial, 214 Toxin-regulated pilus, 6 Toxocara canis, 118 Toxoplasma, [235] [236] [237] [238] [239] [39] [40] 47, 49, 81, 99, [115] [116] [117] [118] [119] 169, [295] [296] 388 Tpr proteins, 8, 336 Trachoma, 18, 219 TRANCE, 80, 86, 98, 117, 164, 170-171, 197-198, 213-214, 217-219, 260, 294, 296-297 43, 49, 117, [168] [169] [239] [240] [241] [242] [335] [336] 39, 119, 388 Trypanosoma brucei, 39, 41, [113] [114] [115] [381] [382] [383] [384] 39, 41, [46] [47] [49] [50] [112] [113] [115] [116] [117] [235] [236] [237] [238] 285, 293, [295] [296] 98, 100-101, 211, 215, 217, 219, 237, 284, 287, 289, 294, 300-302, 358, 364 , 371 immunopathology of tuberculosis, 287-288 Tumor necrosis factor alpha (TNF-␣), 11, 298, 401, 411, 441, 447 acquired immunity, 163, 168-170, 200-201, 240, 248-249, 254 immune evasion and latency, 339, 344-345, 388 innate immunity, 80, 82, 84, 86-87, 114-117, 119, 129-131, 133, 139-144, 146, 149-150, 153- 
INDEX
